Depression and anxiety in age-related macular degeneration
Eung Suk Kim,1 Yonguk Kim,1 Seung-Young Yu,1 Moosang Kim2
1Department of Ophthalmology, Kyung Hee University Hospital, Kyung Hee University, Seoul, 2Department of Ophthalmology, School of Medicine, Kangwon National University, Chuncheon, Korea
We read with great interest the article titled “Treatment satisfaction of patients undergoing ranibizumab therapy for neovascular age-related macular degeneration in a real-life setting” by Gohil et al.1 We are in agreement with their findings. We congratulate the authors for their well-organized study and would like to contribute to their findings.
View the original paper by Gohill and colleagues.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]